首页>
外国专利>
Use of cell-permeable peptide inhibitors of the JNK signaling pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
Use of cell-permeable peptide inhibitors of the JNK signaling pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
展开▼
机译:JNK信号通路的细胞可渗透肽抑制剂在治疗慢性或非慢性炎症性消化系统疾病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory digestive diseases, such as colitis, including e.g. Ulcerative colitis, Crohn's disease, diversion colitis, ischemic colitis, infectious colitis, fulminant colitis, chemical colitis, microscopic colitis, lymphocytic colitis, and atypical colitis, etc..
展开▼